The vaccine industry has undergone a revolution in technology resulting in a variety of novel therapeutic platforms that accelerate development and significantly reduce the duration of process optimization and scale-up. However, challenges in maintaining efficacy and improving process robustness remain. In this presentation, we present a comparison of these novel technologies, discuss key considerations for manufacturing, and share selected case studies for platforms such as virus-like-particles, viral vectors, plasmid DNA, and mRNA platforms.
In this webinar, you will learn:
- Benefits of platform technologies in vaccine development
- Key considerations when deciding between platforms
- Vaccine pipeline analysis and selected case studies
Speakers
David Loong, Ph.D.
MilliporeSigma
Senior Consultant, Novel Modalities Asia Pacific, Bioprocessing Strategy
David Loong is our senior consultant, novel modalities APAC, bioprocessing strategy. Previously, David held roles as a senior scientist in biotech startups encompassing cell & gene therapy process development services, mAb discovery, and preclinical development. He has an extensive track record providing contract research services as a senior research scientist at AMRI Global, and as a product custodian for API GMP manufacturing at GSK. He holds a Ph.D. in synthetic organic chemistry from the Australian National University and a BTech(Hons) from Massey University (NZ) specializing in chemistry and process engineering.
Josephine Cheng
MilliporeSigma
Senior Consultant, Core Modalities Asia Pacific, Bioprocessing Strategy
Josephine is the senior consultant for bioprocessing strategy at MilliporeSigma, focusing on vaccine & mRNA modalities, where she stays on top of the market trends, fosters customer collaborations, supports innovation, leads marketing initiatives, generates publications, and transforms insights into sustainable business strategies. With over 14 years of international biopharma working experience, Josephine has accumulated practical industry knowledge and technical skills from various positions ranging from R&D, application, training, marketing, and strategy. Josephine obtained both bachelor's and master's degrees in bio-resources and agriculture from the National Taiwan University, focusing on protein & molecular science.
Pharma and biopharma manufacturing
- Vaccine manufacturing
Duration:1h 9min
Language:English
Session 1:presented August 3, 2021
To continue reading please sign in or create an account.
Don't Have An Account?